Impact of external quality assessment on antinuclear antibody detection performance

Lupus

Volumn 14, Issue 2, 2005, Pages 113-119

  Pham, Bach Nga ^a   Albarede, S ^b   Guyard, A ^b   Burg, E ^b   Maisonneuve, P ^b  

^a BEAUJON HOSPITAL   (France)

^b AFSSAPS   (France)

Author keywords

Antinuclear antibodies; Autoantibodies; Autoimmunity; External quality assessment; Quality assurance

Indexed keywords

ANTINUCLEAR ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL LABORATORY; CONTROLLED STUDY; FEMALE; FRANCE; HEP 2 CELL; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; MAJOR CLINICAL STUDY; MIXED CONNECTIVE TISSUE DISEASE; PRIORITY JOURNAL; QUALITY CONTROL; SCLERODERMA; SJOEGREN SYNDROME; STANDARDIZATION; STATISTICAL ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTINUCLEAR; CREST SYNDROME; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FRANCE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY;

EID: 14744270139     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2069oa     Document Type: Article

References (21)

1. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44: 93-151.
2. Hahn BH. Antibodies to DNA. N Engl J Med 1998; 338: 1359-1368.
3. Von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995; 24: 323-358.
4. Sharp GC, Irvin WS, May CM et al. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases. N Engl J Med 1976; 295; 1149-1154.
5. Tan EM, Feltkamp TEW, Smolen JS et al. Range of antinuclear antibodies in 'healthy' individuals. Arthritis Rheum 1997; 40: 1601-1611.
6. Craig WY, Ledue TB, Johnson AM, Ritchie RF. The distribution of antinuclear antibody titers in 'normal' children and adults. J Rheumatol 1999; 26: 914-919.
7. Mills JA. Systemic lupus erythematosus. N Engl J Med 1994; 330: 871-879.
8. Prost AC, Abuaf N, Rouquette-Gally AM, Homberg JC, Combrisson A. Comparing HEp-2 cell line with rat liver in routine screening test for antinuclear and antinucleolar autoantibodies in autoimmune diseases. Ann Biol Clin 1987; 45: 610-617.
9. Humbel RL. Detection of antinuclear antibodies by immunofluorescence. In Van Venrooij WJ, Maini RN eds. Manual of biological markers of disease. Dordrecht: Kluwer Academic, 1993: A21-A16.
10. Egner W. The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 2000; 53: 424-432.
11. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
12. Kern P, Kron M, Hiesche K. Measurement of antinuclear antibodies; assessment of different test systems. Clin Diag Lab Immunol 2000; 7: 72-78.
13. Peene I, Meheus L, Veys EM, De Keyser F. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 2001; 60: 1131-1136.
14. Feltkamp TE, Klein F, Janssens MB. Standardisation of the quantitative determination of antinuclear antibodies (ANAs) with a homogeneous pattern. Ann Rheum Dis 1988; 47: 906-909.
15. Molden DP, Nakamura RM, Tan EM. Standardization of the immunofluorescence test for autoantibody to nuclear antigens (ANA): use of reference sera of defined antibody specificity. Am J Clin Pathol 1984; 82: 57-66.
16. Bizzaro N, Tozzoli R, Tonutti E et al. Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies; a collaborative study with the biomedical industry. J Immunol Methods 1998; 219: 99-107.
17. Feltkamp TE. Antinuclear antibody determination in a routine laboratory. Ann Rheum Dis 1996; 55: 723-727.
18. Emlen W, O'Neill L. Clinical significance of antinuclear antibodies. Arthritis Rheum 1997; 40: 1612-1618.
19. Rondeel JMM, Van Gelder W, Van der Leeden H, Dinkelaar RB. Different strategies in the laboratory diagnosis of autoimmune disease: immunofluorescence, enzyme-linked immunosorbent assay or both? Ann Clin Biochem 1999; 36: 189-195.
20. Ulvestad E, Kanestrom A, Madland TM, Thomassen E, Haga HJ, Vollset SE. Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice. Scand J Immunol 2000; 52: 309-315.
21. Bayer PM, Bauerfeind S, Bienvenu J et al. Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay. J Autoimmun 1999; 13: 89-93.